AAAAAA
Results:
1-24
|
Results: 24
Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis
Authors:
Ino, Y
Betensky, RA
Zlatescu, MC
Sasaki, H
Macdonald, DR
Stemmer-Rachamimov, AO
Ramsay, DA
Cairncross, JG
Louis, DN
Citation: Y. Ino et al., Molecular subtypes of anaplastic oligodendroglioma: Implications for patient management at diagnosis, CLIN CANC R, 7(4), 2001, pp. 839-845
Authors:
Bauman, GS
Cairncross, JG
Citation: Gs. Bauman et Jg. Cairncross, Multidisciplinary management of adult anaplastic oligodendrogliomas and anaplastic mixed oligo-astrocytomas, SEM RAD ONC, 11(2), 2001, pp. 170-180
Authors:
Fortin, D
Macdonald, DR
Stitt, L
Cairncross, JG
Citation: D. Fortin et al., PCV for oligodendroglial tumors: In search of prognostic factors for response and survival, CAN J NEUR, 28(3), 2001, pp. 215-223
Authors:
Cairncross, JG
Citation: Jg. Cairncross, Constitutive expression of growth-related oncogene and its receptor in oligodendrogliomas - Comment, NEUROSURGER, 48(4), 2001, pp. 873-873
Authors:
Zlatescu, MC
TehraniYazdi, A
Sasaki, H
Megyesi, JF
Betensky, RA
Louis, DN
Cairncross, JG
Citation: Mc. Zlatescu et al., Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms, CANCER RES, 61(18), 2001, pp. 6713-6715
Authors:
Xu, GW
Nutt, CL
Zlatescu, MC
Keeney, M
Chin-Yee, I
Cairncross, JG
Citation: Gw. Xu et al., Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethy1)-1-nitrosourea, CANCER RES, 61(10), 2001, pp. 4155-4159
Authors:
Louis, DN
Holland, EC
Cairncross, JG
Citation: Dn. Louis et al., Glioma classification - A molecular reappraisal, AM J PATH, 159(3), 2001, pp. 779-786
Authors:
Sasaki, H
Zlatescu, MC
Betensky, RA
Ino, Y
Cairncross, JG
Louis, DN
Citation: H. Sasaki et al., PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis, AM J PATH, 159(1), 2001, pp. 359-367
Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas
Authors:
Bauman, GS
Ino, Y
Ueki, K
Zlatescu, MC
Fisher, BJ
Macdonald, DR
Stitt, L
Louis, DN
Cairncross, JG
Citation: Gs. Bauman et al., Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas, INT J RAD O, 48(3), 2000, pp. 825-830
Authors:
Cairncross, JG
Citation: Jg. Cairncross, Understanding low-grade glioma - A decade of progress, NEUROLOGY, 54(7), 2000, pp. 1402-1403
Authors:
Glantz, MJ
Forsyth, PA
Recht, LD
Wen, PY
Chamberlain, MC
Grossman, SA
Cairncross, JG
Citation: Mj. Glantz et al., Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors - Report of the Quality Standards Subcommittee of the American Academy of Neurology, NEUROLOGY, 54(10), 2000, pp. 1886-1893
Authors:
Ino, Y
Zlatescu, MC
Sasaki, H
MacDonald, DR
Stemmer-Rachamimov, AO
Jhung, S
Ramsay, DA
von Deimling, A
Louis, DN
Cairncross, JG
Citation: Y. Ino et al., Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss, J NEUROSURG, 92(6), 2000, pp. 983-990
Authors:
Louis, DN
Ino, Y
Cairncross, JG
Citation: Dn. Louis et al., High-grade gliomas with chromosome 1p loss - Response, J NEUROSURG, 92(6), 2000, pp. 1081-1081
Authors:
Nutt, CL
Noble, M
Chambers, AF
Cairncross, JG
Citation: Cl. Nutt et al., Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy, CANCER RES, 60(17), 2000, pp. 4812-4818
Authors:
Pohl, U
Cairncross, JG
Louis, DN
Citation: U. Pohl et al., Homozygous deletions of the CDKN2C/p18(INK4C) gene on the short arm of chromosome 1 in anaplastic oligodendrogliomas, BRAIN PATH, 9(4), 1999, pp. 639-643
Authors:
Scott, JN
Rewcastle, NB
Brasher, PMA
Fulton, D
MacKinnon, JA
Hamilton, M
Cairncross, JG
Forsyth, P
Citation: Jn. Scott et al., Which glioblastoma multiforme patient will become a long-term survivor? A population-based study, ANN NEUROL, 46(2), 1999, pp. 183-188
Authors:
DeAngelis, LM
Burger, PC
Green, SB
Cairncross, JG
Citation: Lm. Deangelis et al., Malignant glioma: Who benefits from adjuvant chemotherapy? Reply, ANN NEUROL, 45(6), 1999, pp. 824-824
Authors:
Bauman, G
Lote, K
Larson, D
Stalpers, L
Leighton, C
Fisher, B
Wara, W
MacDonald, D
Stitt, L
Cairncross, JG
Citation: G. Bauman et al., Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis, INT J RAD O, 45(4), 1999, pp. 923-929
Authors:
Nutt, CL
Loktionova, NA
Pegg, AE
Chambers, AF
Cairncross, JG
Citation: Cl. Nutt et al., O-6-methylguanine-DNA methyltransferase activity, p53 gene status and BCNUresistance in mouse astrocytes, CARCINOGENE, 20(12), 1999, pp. 2361-2365
Authors:
Paleologos, NA
Macdonald, DR
Vick, NA
Cairncross, JG
Citation: Na. Paleologos et al., Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma, NEUROLOGY, 53(5), 1999, pp. 1141-1143
Authors:
Taylor, MD
Perry, J
Zlatescu, MC
Stemmer-Rachamimov, AO
Ang, LC
Ino, Y
Schwartz, M
Becker, LE
Louis, DN
Cairncross, JG
Citation: Md. Taylor et al., The hPMS2 exon 5 mutation and malignant glioma, J NEUROSURG, 90(5), 1999, pp. 946-950
Authors:
Perry, JR
Louis, DN
Cairncross, JG
Citation: Jr. Perry et al., Current treatment of oligodendrogliomas, ARCH NEUROL, 56(4), 1999, pp. 434-436
Authors:
Bampoe, JO
Bauman, G
Cairncross, JG
Bernstein, M
Citation: Jo. Bampoe et al., Adult low-grade gliomas: Natural history, prognostic factors, and timing of treatment, PRACTICAL MANAGEMENT OF LOW-GRADE PRIMARY BRAIN TUMORS, 1999, pp. 135-148
Authors:
Mikkelsen, T
Shaw, EG
Bernstein, M
Cairncross, JG
Kim, JH
Rosenblum, ML
Rock, JP
Citation: T. Mikkelsen et al., Practical case scenarios, PRACTICAL MANAGEMENT OF LOW-GRADE PRIMARY BRAIN TUMORS, 1999, pp. 181-189
Risultati:
1-24
|